Bamlanivimab Biosimilar – Anti-Covid Spike RBD mAb – Research Grade

(1 customer review)
Reference:
Size

,

Brand

Product type

Clonality

Expression system

Description of Bamlanivimab Biosimilar - Anti-Covid Spike RBD mAb - Research Grade

Description of Bamlanivimab Biosimilar - Anti-Covid Spike RBD mAb - Research Grade

General information on Anti-SARS-CoV2 Spike RBD (Bamlanivimab) Monoclonal Antibody

Bamlanivimab is a synthetic monoclonal antibody (mAb) that was developped from the first blood samples from COVID-19 recovered patients in the United States. Bamlanivimab is a neutralizing IgG1? mAb targetting the SARS-CoV-2 spike, which prevents the virus from entering human cells. It has been found to recognize first type and variants referenced as PX-COV-P046 and PX-COV-P052.

Product nameBamlanivimab Biosimilar - Anti-Covid Spike RBD mAb - Research Grade
SpeciesHumanized
Molecular weight150kDa
Purity>90%
BufferPBS pH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage condition4°C for short term; -20°C for long term
BrandProteoGenix
Aliases /SynonymsBamlanivimab
ReferencePX-TA1031
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1
ClonalityMonoclonal Antibody
Product nameBamlanivimab Biosimilar - Anti-Covid Spike RBD mAb - Research Grade
SpeciesHumanized
Expression systemMammalian cells
Molecular weight150kDa
Purity>90%
BufferPBS pH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage condition4°C for short term; -20°C for long term
BrandProteoGenix
Aliases /SynonymsBamlanivimab
ReferencePX-TA1031
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1
ClonalityMonoclonal Antibody

1 review for Bamlanivimab Biosimilar – Anti-Covid Spike RBD mAb – Research Grade

  1. Toshi

    This antibody along with other therapeutic antibodies were tested in surrogate virus neutralization test using spike trimers and ACE2 protein. This antibody showed expected neutralization of wild type, Alpha, Gamma, and Delta variants (IC50 135.73 ng/mL for the wild type, 185.54 ng/mL for Alpha, >500 ng/mL for Gamma and Delta).

Add a review

Your email address will not be published.


Clear
OK

Please select the country of delivery so that we can send you the quotation including shipping costs.

Thank you for your request! You will receive your quotation per e-mail in a few seconds.

If you did not receive your quotation, please check your spam folder.

Contact us to order

+33 (0)3 90 20 54 70

Write us

Categories: